Detalles de la búsqueda
1.
Caregiver-reported quality of communication in pancreatic and periampullary cancer.
Cancer
; 130(11): 2051-2059, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146683
2.
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
Ann Surg Oncol
; 31(3): 1980-1989, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044348
3.
Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve Outcomes.
Ann Surg Oncol
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777898
4.
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
Ann Surg Oncol
; 31(3): 1996-2007, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175427
5.
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 31(5): 3314-3324, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310181
6.
Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study.
J Surg Res
; 300: 559-566, 2024 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38925091
7.
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 30(3): 1840-1849, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310315
8.
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
Ann Surg Oncol
; 30(12): 7840-7847, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620532
9.
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis.
Ann Surg Oncol
; 30(9): 5743-5753, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294386
10.
Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
J Surg Oncol
; 127(6): 975-982, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790093
11.
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
J Surg Oncol
; 127(4): 706-715, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36468401
12.
3D versus 2D laparoscopic distal gastrectomy in patients with gastric cancer: a systematic review and meta-analysis.
Surg Endosc
; 37(10): 7914-7922, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37430123
13.
Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experience.
J Surg Oncol
; 126(8): 1375-1382, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36081374
14.
Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC.
Ann Surg Oncol
; 28(7): 3831-3837, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393023
15.
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
Ann Surg Oncol
; 28(8): 4499-4507, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507449
16.
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
J Surg Oncol
; 123(1): 187-195, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002202
17.
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4996-5004, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073341
18.
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
Ann Surg Oncol
; 27(13): 4883-4891, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318945
19.
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC.
Ann Surg Oncol
; 27(13): 4894-4907, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378087
20.
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4980-4995, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696303